Drug Profile
Sodium nitroprusside intravenous - Exela Pharma Sciences
Alternative Names: NIPRIDE RTU; Sodium nitroprusside - RTULatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Exela Pharma Sciences
- Class Antihypertensives; Heart failure therapies; Peripheral vasodilators
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acute heart failure